<DOC>
	<DOCNO>NCT01145807</DOCNO>
	<brief_summary>The aim study establish efficacy , clinical benefit , safety treatment TDT 067 clinically diagnosed distal subungual onychomycosis toenail cause dermatophytes confirm positive mycology .</brief_summary>
	<brief_title>TDT 067 Onychomycosis Study</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>1 . Patients must 18 75 year age inclusive , race , either sex . Female patient must either surgically sterile , postmenopausal ( menses previous 12 month ) , must practice effective method birth control determine Investigator . 2 . Patients must least 1 great toenail ( target toenail ) clinically diagnose distal subungual onychomycosis involve 25 % 65 % , inclusive , nail confirm KOH visualization fungal culture positive dermatophytes . ( Patients culture positive dermatophytes alone dermatophytes non dermatophytes eligible participate . ) If great toenails meet inclusion criterion , one great involvement designate target nail . 3 . Patients must able understand requirement study , abide restriction , return require examination . 4 . Patients must willing sign statement inform consent . 5 . Patients must target great toenail capability grow determine history nail cutting . 6 . Patients must willing refrain use nail polish product nail cosmetic product toenail must willing refrain professional pedicure duration study . 1 . Patients treat investigational drug within 1 month prior study start . 2 . Patients pregnant plan become pregnant lactating . 3 . Patients hypersensitivity terbinafine ingredient formulation . 4 . Patients unable spray toenail surround tissue affected foot without assistance . 5 . Patients symptomatic tinea pedis require treatment . 6 . Patients use oral terbinafine within 6 month prior start study ; patient receive oral antifungal within 3 month . 7 . Patients use topical antifungal treatment onychomycosis within 1 month prior start study ; patient use topical antifungal treatment foot within 1 month prior start study . 8 . Patients nail dystrophy interfere assessment clear nail . Patients toenail abnormality dystrophy could prevent restoration normal appear nail spite mycological cure dermatophytes , include patient psoriasis , lichen planus , malignancy pigmentation disorder involve nail unit , chemical damage , onychodystrophy due trauma structural deformity . 9 . Patients superficial white proximal subungual onychomycosis . 10 . Patients toenail infection involve non dermatophyte alone . 11 . Patients involvement matrix ( lunula ) proximal 2 mm nail measure proximal nail fold . 12 . Patients nail plate thickness great 2 mm total thickness nail plus subungual debris measure great 3 mm . 13 . Patients yellow streak dermatophytoma target toenail . 14 . Patients history peripheral arterial disease diabetes mellitus . 15 . Patients condition opinion Investigator render patient unsuitable participation study . 16 . Patients alanine aminotransferase ( ALT ) aspartate ( AST ) level great 2 time upper limit normal without clinical reason , unless , opinion Investigator , participation study would place patient undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Distal Subungual Toenail Onychomycosis</keyword>
</DOC>